-
1
-
-
33749625270
-
Tobacco smoke and bladder cancer - In the European Prospective Investigation into Cancer and Nutrition
-
DOI 10.1002/ijc.22169
-
Bjerregaard BK, Raaschou-Nielsen O, Sorensen M et al. Tobacco smoke and bladder cancer - in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2006;119:2412-2416. (Pubitemid 44546965)
-
(2006)
International Journal of Cancer
, vol.119
, Issue.10
, pp. 2412-2416
-
-
Bjerregaard, B.K.1
Raaschou-Nielsen, O.2
Soresen, M.3
Frederiksen, K.4
Christensen, J.5
Tjonneland, A.6
Overvad, K.7
Chapelon, F.C.8
Nagel, G.9
Chang-Claude, J.10
Bergmann, M.M.11
Boeing, H.12
Trichopoulos, D.13
Trichopoulou, A.14
Oikonomou, E.15
Berrino, F.16
Palli, D.17
Tumino, R.18
Vineis, P.19
Panico, S.20
Peeters, P.H.M.21
Bueno-De-Mesquita, H.B.22
Kiemeney, L.23
Gram, I.T.24
Braaten, T.25
Lund, E.26
Gonzalez, C.A.27
Berglund, G.28
Allen, N.29
Roddam, A.30
Bingham, S.31
Riboli, E.32
more..
-
2
-
-
33645008244
-
Tumor marker tests in bladder cancer
-
Feil G, Stenzl A. Tumor marker tests in bladder cancer. Actas Urol Esp 2006;30:38-45.
-
(2006)
Actas Urol. Esp
, vol.30
, pp. 38-45
-
-
Feil, G.1
Stenzl, A.2
-
3
-
-
0642280213
-
Urinzytologie beim Harnblasenkarzinom. Diagnostische Wertigkeit eines neuen immunologischen Fluoreszenztestes
-
Feil G, Bichler KH, Päulgen-Nelde HJ, Hennenlotter J, Zumbrägel A, Stenzl A. Urinzytologie beim Harnblasenkarzinom. Diagnostische Wertigkeit eines neuen immunologischen Fluoreszenztestes. Urologe A 2003;42:531-537.
-
(2003)
Urologe a
, vol.42
, pp. 531-537
-
-
Feil, G.1
Bichler, K.H.2
Päulgen-Nelde, H.J.3
Hennenlotter, J.4
Zumbrägel, A.5
Stenzl, A.6
-
4
-
-
30044446209
-
Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
-
DOI 10.1016/j.urology.2005.08.065, PII S0090429505014937
-
Habuchi T, Marberger M, Droller MJ et al. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology 2005;66(Suppl 1):64-74. (Pubitemid 43049609)
-
(2005)
Urology
, vol.66
, Issue.6 SUPPL. 1
, pp. 64-74
-
-
Habuchi, T.1
Marberger, M.2
Droller, M.J.3
Hemstreet III, G.P.4
Grossman, H.B.5
Schalken, J.A.6
Schmitz-Drager, B.J.7
Murphy, W.M.8
Bono, A.V.9
Goebell, P.10
Getzenberg, R.H.11
Hautmann, S.H.12
Messing, E.13
Fradet, Y.14
Lokeshwar, V.B.15
-
5
-
-
33847058536
-
Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder
-
Hungerhuber E, Stepp H, Kriegmair M et al. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 2007;69:260-264.
-
(2007)
Urology
, vol.69
, pp. 260-264
-
-
Hungerhuber, E.1
Stepp, H.2
Kriegmair, M.3
-
6
-
-
30044450417
-
International Consensus Panel on bladder tumor markers
-
International Consensus Panel on bladder tumor markers. Urology 2005;66(Suppl 1):35-63.
-
(2005)
Urology
, vol.66
, Issue.1 SUPPL.
, pp. 35-63
-
-
-
7
-
-
30044450417
-
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
-
DOI 10.1016/j.urology.2005.08.064, PII S0090429505014925
-
Lokeshwar VB, Habuchi T, Grossman HB et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology 2005;66(Suppl 1):35-63. (Pubitemid 43049608)
-
(2005)
Urology
, vol.66
, Issue.6 SUPPL. 1
, pp. 35-63
-
-
Lokeshwar, V.B.1
Habuchi, T.2
Grossman, H.B.3
Murphy, W.M.4
Hautmann, S.H.5
Hemstreet III, G.P.6
Bono, A.V.7
Getzenberg, R.H.8
Goebell, P.9
Schmitz-Drager, B.J.10
Schalken, J.A.11
Fradet, Y.12
Marberger, M.13
Messing, E.14
Droller, M.J.15
-
9
-
-
33747877159
-
Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis
-
Lotan Y, Svatek RS, Sagalowsky Al. Should we screen for bladder cancer in a high-risk population? A cost per life-year saved analysis. Cancer 2006;107:982-990.
-
(2006)
Cancer
, vol.107
, pp. 982-990
-
-
Lotan, Y.1
Svatek, R.S.2
Al, S.3
-
10
-
-
0034036433
-
Occupational risk factors for urothelial carcinoma: Agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter Urothelial and Renal Cancer
-
Pesch B, Haerting J, Ranft U, Klimpel A, Oelschlagel B, Schill W. Occupational risk factors for urothelial carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter Urothelial and Renal Cancer. Int J Epidemiol 2000;29:238-247.
-
(2000)
Int. J. Epidemiol
, vol.29
, pp. 238-247
-
-
Pesch, B.1
Haerting, J.2
Ranft, U.3
Klimpel, A.4
Oelschlagel, B.5
Schill, W.6
-
11
-
-
0043160408
-
Urinzytologie beim Harnblasenkarzinom: Kritische Wertung
-
Rathert P. Urinzytologie beim Harnblasenkarzinom: Kritische Wertung. Urologe A 2003;42:908-911.
-
(2003)
Urologe A
, vol.42
, pp. 908-911
-
-
Rathert, P.1
-
12
-
-
0029353226
-
Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis
-
Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 1995;33:828-841.
-
(1995)
Med. Care
, vol.33
, pp. 828-841
-
-
Riley, G.F.1
Potosky, A.L.2
Lubitz, J.D.3
Kessler, L.G.4
-
13
-
-
77956448982
-
-
Häufigkeiten und Trends. 6. überarb. Aufl. Robert Koch-Institut Hrsg und die Gesellschaft der epidemiologischen Krebsregister in Deutschl and e. V. Hrsg. Berlin: RKI
-
RKI. Krebs in Deutschland 2003-2004. Häufigkeiten und Trends. 6. überarb. Aufl. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschl and e. V. (Hrsg). Berlin: RKI, 2008; S. 82-85.
-
(2008)
RKI. Krebs in Deutschland 2003-2004
-
-
-
14
-
-
33745712627
-
Diagnostic tests and algorithms used in the investigation of haematuria: Systematic reviews and economic evaluation
-
Rodgers M, Nixon J, Hempel S et al. Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technol Assess 2006;10:iii-iv, xi-259.
-
(2006)
Health Technol. Assess
, vol.10
, Issue.3-4
, pp. 11-259
-
-
Rodgers, M.1
Nixon, J.2
Hempel, S.3
-
15
-
-
34147135185
-
The epidemiology of bladder and kidney cancer
-
Scelo G, Brennan P: The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol 2007;4:205-217.
-
(2007)
Nat. Clin. Pract. Urol.
, vol.4
, pp. 205-217
-
-
Scelo, G.1
Brennan, P.2
-
16
-
-
67349137406
-
Economic aspects of bladder cancer: What are the benefits and costs?
-
Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, Kruck S, Stenzl A. Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 2009;27:295-300.
-
(2009)
World J. Urol.
, vol.27
, pp. 295-300
-
-
Sievert, K.D.1
Amend, B.2
Nagele, U.3
Schilling, D.4
Bedke, J.5
Horstmann, M.6
Hennenlotter, J.7
Kruck, S.8
Stenzl, A.9
-
17
-
-
49349114343
-
Photodynamische Diagnostik im Harntrakt. Konsensusempfehlungen des Arbeitskreises Onkologie der Deutschen Gesellschaft für Urologie
-
Stenzl A, Jocham D, Jichlinska P et al. Photodynamische Diagnostik im Harntrakt. Konsensusempfehlungen des Arbeitskreises Onkologie der Deutschen Gesellschaft für Urologie. Urologe A 2008;47:982-987.
-
(2008)
Urologe a
, vol.47
, pp. 982-987
-
-
Stenzl, A.1
Jocham, D.2
Jichlinska, P.3
-
18
-
-
51949100319
-
Is there a rationale for bladder cancer screening?
-
Svatek RS, Lotan Y: Is there a rationale for bladder cancer screening? Curr Urol Rep 2008;9:339-341.
-
(2008)
Curr. Urol. Rep.
, vol.9
, pp. 339-341
-
-
Svatek, R.S.1
Lotan, Y.2
-
19
-
-
35048854039
-
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer
-
Review
-
Witjes JA, Douglass J. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer. Nat Clin Pract Urol 2007;4:542-549. Review.
-
(2007)
Nat. Clin. Pract. Urol.
, vol.4
, pp. 542-549
-
-
Witjes, J.A.1
Douglass, J.2
|